BVMF/FMSC34 (BVMF/FMSC34)

Brazil Stock Exchange: BVMF/FMSC34 · BRL

R$123

+0.00 (0.0%)· Recorded snapshot

Market cap	64.4B
Revenue (ttm)	115B
Net income (ttm)	5.6B
EPS (ttm)	R$9.96
P/E (trailing)	12.3x
P/E (forward)	10.0x
Dividend	R$3.03 (2.47%)
Volume	0
Beta	0.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 115B
Net income (ttm): 5.6B
EPS (ttm): R$9.96
P/E (trailing): 12.3x
P/E (forward): 10.0x
Market cap: 64.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E10

P25 n/aP50 n/aP75 n/a

Trailing P/E12.3

P25 n/aP50 n/aP75 n/a

ROE8.5

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/FMSC34 indicators

Market & fundamental data

Available fields

230

Groups with data

Currency

EUR

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Germany
Country code	BR
Earnings date	2026-11-03
Employees	107,226
Employees change	-5,219
Employees growth	-4.64%
Enterprise value	BRL 129.7B
Exchange	Brazil Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	BRFMSCBDR001
Last earnings date	2026-08-04
Last refreshed	2026-10-29
Market cap	BRL 64.4B
Next earnings date	2026-11-03
Price	BRL 122.50
Price currency	BRL
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-26
Symbol	bvmf/FMSC34
Website	https://www.freseniusmedicalcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	17.72x
Average P/E ratio (3Y)	18.9x
Average P/E ratio (5Y)	18.31x
Earnings yield	8.13%
EV/Earnings	23.36x
EV/EBIT	10.4x
EV/EBITDA	6.28x
EV/FCF	12.27x
EV/Sales	1.11x
FCF / EV yield	8.15%
FCF yield	16.39%
Forward P/E	10.02x
Graham number	190.12491
Graham upside	55.2%
Lynch fair value	BRL 52.76
Lynch upside	-56.93%
P/B ratio	0.8x
P/E ratio	12.3x
P/FCF ratio	6.1x
P/OCF ratio	3.85x
P/S ratio	0.56x
Price/EBITDA ratio	4x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.26%
EBITDA margin	14.01%
Effective tax rate	20.93%
FCF margin	9.13%
Gross margin	26.36%
Operating margin	10.26%
Pretax margin	7.73%
Profit margin	4.83%
Profit per employee	BRL 51,766
Profitable quarters	98
Profitable years	26
Revenue per employee	BRL 1.1M
ROA	3.98%
ROA (5Y)	3.11%
ROCE	8.26%
ROE	8.52%
ROE (5Y)	6.59%
ROIC	6.64%
ROIC (5Y)	4.94%
Tax / revenue	1.62%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	49.98%
EPS growth (Q)	5.5%
EPS growth (QoQ)	89.7%
EPS growth 10Y	0.22%
EPS growth 3Y	18.11%
EPS growth 5Y	-0.38%
EPS growth quarters	1
EPS growth years	2
FCF growth	-12.85%
FCF growth (Q)	-0.1%
FCF growth (QoQ)	1,583.56%
FCF growth 3Y	1.24%
FCF growth 5Y	3.36%
Gross profit growth	6.34%
Gross profit growth (Q)	7.87%
Gross profit growth 3Y	2.03%
Gross profit growth 5Y	-0.41%
Net income growth	42.86%
Net income growth (Q)	-3.06%
Net income growth (QoQ)	85.81%
Net income growth 3Y	16.33%
Net income growth 5Y	-1.24%
Net income growth years	2
OCF growth	2.77%
OCF growth (Q)	11.02%
OCF growth (QoQ)	279.18%
OCF growth 10Y	4.73%
OCF growth 3Y	5.55%
OCF growth 5Y	2.86%
Operating income growth	26.09%
Operating income growth (Q)	32.77%
Operating income growth 3Y	9.03%
Operating income growth 5Y	-0.48%
Revenue growth	-0.47%
Revenue growth (Q)	1.44%
Revenue growth (QoQ)	5.39%
Revenue growth 10Y	2.06%
Revenue growth 3Y	-0.33%
Revenue growth 5Y	2.29%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -6.2B
Depreciation and amortization	BRL 4.3B
EBIT	BRL 11.8B
EBITDA	BRL 16.1B
EPS	BRL 9.96
Financing cash flow	BRL -15.1B
Free cash flow	BRL 10.6B
Gross profit	BRL 30.3B
Income taxes	BRL 1.9B
Investing cash flow	BRL -5.4B
Net borrowing	BRL -2.9B
Net cash flow	BRL -3.9B
Net income	BRL 5.6B
Operating income	BRL 11.8B
Revenue	BRL 115B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.78
Book value per share	BRL 279.29
Debt / EBITDA	3.27
Debt / equity	0.81
Debt / FCF	6.15
Goodwill	BRL 83.2B
Interest coverage	5.2
Long-term assets	BRL 139.4B
Long-term liabilities	BRL 62.4B
Net cash (debt)	BRL -58.7B
Net cash / market cap	-91.09%
Net debt / EBITDA	3.64
Net debt / equity	0.73
Net debt / FCF	5.56
Piotroski F-Score	7
Property, plant and equipment	BRL 38.3B
Shareholders' equity	BRL 80.1B
Tangible book value	BRL -15.9B
Tangible book value per share	BRL -59.86
Total assets	BRL 185.2B
Total cash	BRL 6.3B
Total debt	BRL 65B
Total liabilities	BRL 105.1B
WACC	5.71%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	BRL 45.8B
Current liabilities	BRL 42.7B
Current ratio	1.07
Inventory turnover	6.61
Net working capital	BRL 10.6B
Quick ratio	0.63
Working capital	BRL 3B
Working capital turnover	76.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.44%
Dividend growth	-1.38%
Dividend growth (3Y)	15.05%
Dividend growth years	2
Dividend payment date	2026-06-12
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	BRL 3.03
Dividend yield	2.47%
Ex-dividend date	2026-05-21
Last dividend	BRL 3.03
Payout ratio	42.67%
Shareholder yield	6.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 111.17
1D price change	0%
1M price change	7.46%
1M total return	7.46%
1W price change	8.86%
1W total return	8.86%
1Y price change	-6.84%
1Y return CAGR	-4.26%
1Y total return	-4.26%
20-day SMA	BRL 117.51
3M price change	-1.18%
3M total return	-1.18%
3Y price change	44.12%
3Y return CAGR	15.5%
3Y total return	54.09%
50-day SMA	BRL 123.26
52-week high	BRL 128.96
52-week high date	2025-11-25
52-week low	BRL 105.05
52-week low date	2026-05-13
6M price change	1.88%
6M total return	4.71%
All-time high	BRL 165.95
All-time high date	2025-05-19
All-time low	BRL 66.66
All-time low date	2022-10-10
Average true range (ATR)	BRL 4.13
Average volume	150.3
Beta (5Y)	0.81
Change from 52-week high	-5.01%
Change from 52-week low	16.61%
Change from all-time high	-26.18%
Change from all-time low	83.77%
Change from open	0%
Day's gap	0%
High price	BRL 122.50
Low price	BRL 122.50
Monthly RSI	53.91
Open price	BRL 122.50
Previous close	BRL 122.50
Price vs 150-day SMA	10.19%
Price vs 20-day SMA	4.24%
Price vs 50-day SMA	-0.61%
Relative volume	1.66
RSI	51.97
Sharpe ratio	1.18
Sortino ratio	2.08
Volume	0
Weekly RSI	57.94
YTD price change	-4.24%
YTD total return	-1.58%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	197.8M
Shares change (QoQ)	-2.47%
Shares change (YoY)	-4.44%
Shares held by insiders	0.04%
Shares held by institutions	48.44%

Deeper analysis on BVMF/FMSC34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/FMSC34 report

Is a complete BVMF/FMSC34 research report available?

No complete published report is available for bvmf/FMSC34 (BVMF/FMSC34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/FMSC34 (BVMF/FMSC34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/FMSC34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/FMSC34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/FMSC34

Frequently asked questions